Selection and Characterization of Artificial Proteins Targeting the Tubulin α Subunit.


Journal

Structure (London, England : 1993)
ISSN: 1878-4186
Titre abrégé: Structure
Pays: United States
ID NLM: 101087697

Informations de publication

Date de publication:
05 03 2019
Historique:
received: 26 07 2018
revised: 24 10 2018
accepted: 03 12 2018
pubmed: 22 1 2019
medline: 13 3 2020
entrez: 22 1 2019
Statut: ppublish

Résumé

Microtubules are cytoskeletal filaments of eukaryotic cells made of αβ-tubulin heterodimers. Structural studies of non-microtubular tubulin rely mainly on molecules that prevent its self-assembly and are used as crystallization chaperones. Here we identified artificial proteins from an αRep library that are specific to α-tubulin. Turbidity experiments indicate that these αReps impede microtubule assembly in a dose-dependent manner and total internal reflection fluorescence microscopy further shows that they specifically block growth at the microtubule (-) end. Structural data indicate that they do so by targeting the α-tubulin longitudinal surface. Interestingly, in one of the complexes studied, the α subunit is in a conformation that is intermediate between the ones most commonly observed in X-ray structures of tubulin and those seen in the microtubule, emphasizing the plasticity of tubulin. These α-tubulin-specific αReps broaden the range of tools available for the mechanistic study of microtubule dynamics and its regulation.

Identifiants

pubmed: 30661854
pii: S0969-2126(18)30457-X
doi: 10.1016/j.str.2018.12.001
pmc: PMC6408325
pii:
doi:

Substances chimiques

Peptide Library 0
Recombinant Fusion Proteins 0
Tubulin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

497-506.e4

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : FC001163
Pays : United Kingdom
Organisme : Cancer Research UK
ID : FC001163
Pays : United Kingdom
Organisme : Wellcome Trust
ID : FC001163
Pays : United Kingdom

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Nat Cell Biol. 2015 Nov;17(11):1422-34
pubmed: 26414402
J Struct Biol. 2018 Feb;201(2):88-99
pubmed: 28823563
Science. 2012 Aug 17;337(6096):857-60
pubmed: 22904013
Nat Cell Biol. 2014 Aug;16(8):804-11
pubmed: 24997520
J Mol Biol. 2011 Sep 9;412(1):35-42
pubmed: 21787788
Protein Sci. 2011 Mar;20(3):482-91
pubmed: 21213247
J Cell Biol. 2017 Sep 4;216(9):2669-2677
pubmed: 28652389
Biochemistry. 2005 Nov 8;44(44):14616-25
pubmed: 16262261
Annu Rev Cell Dev Biol. 1997;13:83-117
pubmed: 9442869
Cell. 2000 Sep 15;102(6):809-16
pubmed: 11030624
Nat Commun. 2018 Apr 25;9(1):1662
pubmed: 29695795
Methods Enzymol. 1991;196:478-85
pubmed: 2034137
Dev Cell. 2016 May 23;37(4):362-376
pubmed: 27219064
J Biol Chem. 2014 Sep 5;289(36):25199-210
pubmed: 25056950
PLoS One. 2013 Aug 27;8(8):e71512
pubmed: 24014183
Methods Mol Med. 2007;137:235-43
pubmed: 18085233
J Biol Chem. 2012 Apr 27;287(18):15143-53
pubmed: 22403406
J Am Chem Soc. 2014 Sep 10;136(36):12615-23
pubmed: 25162583
Cell Struct Funct. 1999 Oct;24(5):299-303
pubmed: 15216886
Nat Struct Mol Biol. 2018 Jul;25(7):607-615
pubmed: 29967541
Nat Commun. 2014 Nov 14;5:5364
pubmed: 25395082
Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):E6191-E6200
pubmed: 29915050
Protein Expr Purif. 2003 Nov;32(1):83-8
pubmed: 14680943
Elife. 2014 Aug 05;3:e03069
pubmed: 25097237
Biochemistry. 1997 Sep 9;36(36):10817-21
pubmed: 9312271
J Biol Chem. 2012 Sep 7;287(37):31085-94
pubmed: 22791712
Methods Cell Biol. 2010;95:555-80
pubmed: 20466153
Nat Struct Mol Biol. 2017 Nov;24(11):931-943
pubmed: 28991265
J Mol Biol. 2001 Nov 9;313(5):1045-57
pubmed: 11700061
J Am Chem Soc. 2015 Jul 29;137(29):9218-21
pubmed: 26165802
FEBS Lett. 2013 Nov 1;587(21):3450-5
pubmed: 24021646
Sci Rep. 2016 Jul 06;6:28922
pubmed: 27380724
Curr Biol. 2014 Feb 17;24(4):372-84
pubmed: 24508171
Cell. 1999 Jan 8;96(1):79-88
pubmed: 9989499
J Cell Biol. 2013 Feb 4;200(3):259-70
pubmed: 23358242
Nat Cell Biol. 2016 Oct;18(10):1102-8
pubmed: 27617931
Annu Rev Pharmacol Toxicol. 2015;55:489-511
pubmed: 25562645
J Biol Chem. 2016 Jun 17;291(25):12907-15
pubmed: 27129203
Biochemistry. 1989 Nov 14;28(23):9143-52
pubmed: 2605248
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10037-41
pubmed: 11517324
Biochemistry. 2011 Oct 11;50(40):8636-44
pubmed: 21888381
Nat Struct Mol Biol. 2013 Aug;20(8):1001-7
pubmed: 23872990
Cell. 2015 Aug 13;162(4):849-59
pubmed: 26234155
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Nature. 2004 Mar 11;428(6979):198-202
pubmed: 15014504
Science. 2013 Feb 1;339(6119):587-90
pubmed: 23287720
J Mol Biol. 2010 Nov 26;404(2):307-27
pubmed: 20887736
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12011-6
pubmed: 22778434
Dev Cell. 2016 Apr 4;37(1):72-84
pubmed: 27046833
Nat Commun. 2017 Jul 10;8(1):70
pubmed: 28694425
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Curr Opin Struct Biol. 2017 Oct;46:65-70
pubmed: 28628789

Auteurs

Valérie Campanacci (V)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette Cedex 91198, France.

Agathe Urvoas (A)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette Cedex 91198, France.

Tanja Consolati (T)

The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

Soraya Cantos-Fernandes (S)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette Cedex 91198, France.

Magali Aumont-Nicaise (M)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette Cedex 91198, France.

Marie Valerio-Lepiniec (M)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette Cedex 91198, France.

Thomas Surrey (T)

The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

Philippe Minard (P)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette Cedex 91198, France. Electronic address: philippe.minard@i2bc.paris-saclay.fr.

Benoît Gigant (B)

Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette Cedex 91198, France. Electronic address: benoit.gigant@i2bc.paris-saclay.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH